Substitution of Generic Drugs and Biosimilars

JAMA Intern Med. 2021 Apr 1;181(4):567-568. doi: 10.1001/jamainternmed.2020.8561.

Authors

Sang Kyu Cho¹, Hankyung Jun²

Affiliations

¹ Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, Texas.
² Sol Price School of Public Policy, University of Southern California, Los Angeles.

PMID: 33492392
DOI: 10.1001/jamainternmed.2020.8561

No abstract available

Publication types

Comment

MeSH terms

Biosimilar Pharmaceuticals*
Drugs, Generic
Humans

Substances

Biosimilar Pharmaceuticals
Drugs, Generic